First Heartland Consultants, Inc. Q2 2016 Filing
Filed August 12, 2016
Portfolio Value
$912.1B
Holdings
303
Report Date
Q2 2016
Filing Type
13F-HR
All Holdings (303 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 301 | —CTI BIOPHARMA CORP | 14,924 | $5.0M | 0.00% | |
| 302 | —REXAHN PHARMACEUTICALS INC | 21,500 | $5.0M | 0.00% | |
| 303 | —NEURALSTEM INC | 10,000 | $3.0M | 0.00% |
PreviousPage 4 of 4